Formyltetrahydrofolates
Showing 1 - 16 of 16
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Gastric Cancer Trial in Australia, New Zealand (drug, radiation, procedure)
Active, not recruiting
- Gastric Cancer
- Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
- +2 more
-
Newcastle, New South Wales, Australia
- +22 more
Mar 21, 2022
Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil
Recruiting
- Colon Cancer
- +4 more
- 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 15, 2022
Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum Trial in Richmond
Completed
- Mucinous Adenocarcinoma of the Rectum
- +9 more
- intensity-modulated radiation therapy
- +4 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Jul 19, 2021
Colorectal Adenocarcinoma, RAS Wild Type, Stage III Colorectal Cancer AJCC v7 Trial in Los Angeles (biological, drug, other)
Terminated
- Colorectal Adenocarcinoma
- +8 more
- Panitumumab
- +6 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Jun 8, 2020
Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,
Completed
- Pancreatic Adenocarcinoma
- +4 more
- Oxaliplatin
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020
Cancer of Rectum, Cancer of the Rectum, Tumor, Rectum Trial in Saint Louis (Radiation, Oxaliplatin, Leucovorin)
Completed
- Cancer of Rectum
- +6 more
- Radiation
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 10, 2021
Stomach Tumors, Esophageal Tumors Trial in Saint Louis (Irinotecan, Trastuzumab, Oxaliplatin)
Completed
- Stomach Neoplasms
- Esophageal Neoplasms
- Irinotecan
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 12, 2020
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Boston
Completed
- Rectal Mucinous Adenocarcinoma
- +10 more
- Radiotherapy
- +4 more
-
Boston, MassachusettsEastern Cooperative Oncology Group
Dec 3, 2018
Colorectal Cancer Trial in United States (bevacizumab, fluorouracil, irinotecan HCl)
Completed
- Colorectal Cancer
- bevacizumab
- +4 more
-
Greenbrae, California
- +109 more
Jul 23, 2018
Colorectal Cancer Trial in Maywood (fluorouracil, leucovorin calcium)
Terminated
- Colorectal Cancer
- fluorouracil
- leucovorin calcium
-
Maywood, IllinoisLoyola University Medical Center
Jul 19, 2016
Stomach Tumors, Esophageal Tumors Trial in United States (5-fluorouracil, Oxaliplatin, Leucovorin)
Completed
- Stomach Neoplasms
- Esophageal Neoplasms
- 5-fluorouracil
- +2 more
-
Birmingham, Alabama
- +3 more
Dec 8, 2015
Gastric Cancer Trial in Changchun (S-1, leucovorin, oxaliplatin)
Unknown status
- Gastric Cancer
- S-1, leucovorin, oxaliplatin
-
Changchun, Jilin, ChinaJilin Provincial Tumor Hospital
Mar 4, 2015
Carcinoma, Liver Diseases, Hepatocellular Carcinoma Trial in Shanghai (S-1 combined with Leucovorin)
Unknown status
- Carcinoma
- +2 more
- S-1 combined with Leucovorin
-
Shanghai, Shanghai, ChinaEastern Hepatobiliary Surgery Hospital
Feb 14, 2012
Mild Hyperhomocysteinemia Trial in Nijmegen (5-formyltetrahydrofolate (10 mg/ml) (Pharmachemie bv))
Completed
- Mild Hyperhomocysteinemia
- 5-formyltetrahydrofolate (10 mg/ml) (Pharmachemie bv)
-
Nijmegen, NetherlandsRadboud University Medical center Nijmegen
May 5, 2009